Endocytotic segregation of gliadin peptide 31-49 in enterocytes

Gut

Volumn 59, Issue 3, 2010, Pages 300-310

  Zimmer, Klaus Peter ^a   Fischer, Ina ^b   Mothes, Thomas ^c   Weissen Plenz, Gabriele ^d   Schmitz, Martina ^d   Wieser, Herbert ^e   Büning, Jürgen ^f   Lerch, Markus M ^g   Ciclitira, Paul C ^h   Weber, Peter ⁱ   Naim, Hassan Y ^b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

^f Medizinische Klinik II   (Germany)

^g UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^h ST THOMAS HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; EPITOPE; GLIADIN; GLIADIN ANTIBODY; GLIADIN PEPTIDE AA 31 49; HLA DR ANTIGEN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; BASOLATERAL MEMBRANE; CELIAC DISEASE; CELL TRANSPORT; CHILD; DUODENUM BIOPSY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DUODENUM; ENDOCYTOSIS; ENDOSOMES; ENTEROCYTES; EPITOPES; GLIADIN; HLA-DR ANTIGENS; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 77749320438     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.169656     Document Type: Article

References (46)

1. Maki M, Collin P. Coeliac disease. Lancet 1997;349:1755-9.
2. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002;2:647-55.
3. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005;129:1294-301.
4. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
5. Anderson RP, Degano P, Godkin AJ, et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6:337-42.
6. Fraser JS, Engel W, Ellis HJ, et al. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 2003;52:1698-702.
7. Sturgess R, Day P, Ellis HJ, et al. Wheat peptide challenge in coeliac disease. Lancet 1994;343:758-61.
8. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
9. Hue S, Mention JJ, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77.
10. Arentz-Hansen H, Korner R, Molberg O, et al. The intestinal T cell response to alphagliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191:603-12.
11. Arentz-Hansen H, McAdam SN, Molberg O, et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002;123:803-9.
12. Berin MC, Kiliaan AJ, Yang PC, et al. Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856-64.
13. Heyman M, Desjeux JF. Significance of intestinal food protein transport. J Pediatr Gastroenterol Nutr 1992;15:48-57.
14. Bendix U, Lentz S, Rothschild M, et al. Effect of gamma-interferon on binding of gliadin and other food peptides to the human intestinal cell line HT-29. Clin Chim Acta 1997;261:69-80.
15. Bolte G, Seilmeier W, Wieser H, et al. Enhanced peptide-binding capacities of small intestinal brush border membranes in celiac disease. Pediatr Res 1999;46:666-70.
16. Zimmer KP, Poremba C, Weber P, et al. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 1995;36:703-9.
17. Zimmer KP, Naim H, Weber P, et al. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes. FASEB J 1998;12:1349- 57.
18. Bhagat G, Naiyer AJ, Shah JG, et al. Small intestinal CD8+TCRgammadelta +NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest 2008;118:281-93.
19. Nieuwenhuis EE, Blumberg RS. The role of the epithelial barrier in inflammatory bowel disease. Adv Exp Med Biol 2006;579:108-16.
20. Peters PJ, Neefjes JJ, Oorschot V, et al. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991;349:669-76.
21. Rowell JF, Ruff AL, Guarnieri FG, et al. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J Immunol 1995;155:1818-28.
22. Zimmer KP, Buning J, Weber P, et al. Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes. Gastroenterology 2000;118:128-37.
23. Furrie E, Turner MW, Strobel S. Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system. Immunology 1994;83:562-7.
24. Sanchez D, Tuckova L, Burkhard M, et al. Specificity analysis of anti-gliadin mouse monoclonal antibodies used for detection of gliadin in food for gluten-free diet. J Agric Food Chem 2007;55:2627-32.
25. Plenz G, Koenig C, Severs NJ, et al. Smooth muscle cells express granulocyteemacrophage colony-stimulating factor in the undiseased and atherosclerotic human coronary artery. Arterioscler Thromb Vasc Biol 1997;17:2489-99.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Naim HY, Lacey SW, Sambrook JF, et al. Expression of a full-length cDNA coding for human intestinal lactase-phlorizin hydrolase reveals an uncleaved, enzymatically active, and transport-competent protein. J Biol Chem 1991;266:12313-20.
28. Osman AA, Uhlig HH, Valdes I, et al. A monoclonal antibody that recognizes a potential coeliac-toxic repetitive pentapeptide epitope in gliadins. Eur J Gastroenterol Hepatol 2001;13:1189-93.
29. Kahlenberg F, Sanchez D, Lachmann I, et al. Monoclonal antibody R5 for detection of putatively coeliac-toxic gliadin peptides. European Food Research and Technology 2006;222:78-82.
30. Simonsen A, Pedersen KW, Nordeng TW, et al. Polarized transport of MHC class II molecules in MadineDarby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain. J Immunol 1999;163:2540-8.
31. Hershberg RM, Framson PE, Cho D, et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest 1997;100:204-15.
32. Mayer L, Eisenhardt D, Salomon P, et al. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology 1991;100:3-12.
33. Sun JB, Xiao BG, Lindblad M, et al. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Int Immunol 2000;12:1449-57.
34. Mobius W, Herzog V, Sandhoff K, et al. Intracellular distribution of a biotin-labelled ganglioside, GM1, by immunoelectron microscopy after endocytosis in fibroblasts. J Histochem Cytochem 1999;47:1005-14.
35. Dotan I, Allez M, Nakazawa A, et al. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 2007;292:G1630-40.
36. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cellsdpolarity and complexity. Immunol Today 2000;21:123-8.
37. Matysiak-Budnik T, Candalh C, Dugave C, et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 2003;125:696-707.
38. Buning J, Schmitz M, Repenning B, et al. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes. Eur J Immunol 2005;35:831-42.
39. Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998;19:173-81.
40. Dubois B, Goubier A, Joubert G, et al. Oral tolerance and regulation of mucosal immunity. Cell Mol Life Sci 2005;62:1322-32.
41. Bonamico M, Mazzilli MC, Morellini M, et al. Expression of class II MHC antigens in the intestinal epithelium of pediatric celiac disease. J Pediatr Gastroenterol Nutr 1989;9:269-75.
42. Londei M, Ciacci C, Ricciardelli I, et al. Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol 2005;42:913-8.
43. Meresse B, Ripoche J, Heyman M, et al. Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2009;2:8-23.
44. Meresse B, Cerf-Bensussan N. Innate T cell responses in human gut. Semin Immunol 2009;21:121-9.
45. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008;205:143-54.
46. Sun JB, Raghavan S, Sjoling A, et al. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25-CD4+ regulatory T cells. J Immunol 2006;177:7634-44.